Tag: Molecular Nuclear Medicine
![ebrahim delpassand md](https://www.carcinoid.org/wp-content/uploads/2012/11/ebrahim-delpassand-md.jpg)
First U.S. Center to Enroll Patients in International, Multicenter Clinical Trial of Lu-177 Octreotate
November 20, 2012
Excel Diagnostics and Nuclear Oncology Center in Houston, Texas, is the first center in the United States to start recruiting patients in a multicenter randomized clinical trial of Lu-177 Octreotate in patients with progressive midgut carcinoid. …
READ MORE